87 related articles for article (PubMed ID: 27629130)
21. Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125.
Mckinnon B; Mueller MD; Nirgianakis K; Bersinger NA
Mol Med Rep; 2015 Oct; 12(4):5179-84. PubMed ID: 26165164
[TBL] [Abstract][Full Text] [Related]
22. [HE4--a new tumor marker for ovarian cancer].
Manolov V; Marinov B; Vasilev V; Andreeva A
Akush Ginekol (Sofiia); 2011; 50 Suppl 2():11-5. PubMed ID: 22524132
[TBL] [Abstract][Full Text] [Related]
23. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
Moore RG; McMeekin DS; Brown AK; DiSilvestro P; Miller MC; Allard WJ; Gajewski W; Kurman R; Bast RC; Skates SJ
Gynecol Oncol; 2009 Jan; 112(1):40-6. PubMed ID: 18851871
[TBL] [Abstract][Full Text] [Related]
24. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates.
Liao JB; Yip YY; Swisher EM; Agnew K; Hellstrom KE; Hellstrom I
Gynecol Oncol; 2015 Jun; 137(3):430-5. PubMed ID: 25866324
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population.
Kim YM; Whang DH; Park J; Kim SH; Lee SW; Park HA; Ha M; Choi KH
Clin Chem Lab Med; 2011 Mar; 49(3):527-34. PubMed ID: 21320028
[TBL] [Abstract][Full Text] [Related]
26. [HE4 a biomarker of ovarian cancer].
Presl J; Kučera R; Topolčan O; Novotný Z; Vrzalová J; Fuchsova R; Betincová L; Rokyta Z
Ceska Gynekol; 2012 Oct; 77(5):445-9. PubMed ID: 23116350
[TBL] [Abstract][Full Text] [Related]
27. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
Bian J; Sun X; Li B; Ming L
Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
[TBL] [Abstract][Full Text] [Related]
28. [Ovarian tumor markers of presumed benign ovarian tumors].
Lahlou N; Brun JL
J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):752-9. PubMed ID: 24210243
[TBL] [Abstract][Full Text] [Related]
29. Serum concentrations of HE4 change little during in vitro fertilization.
Hallamaa M; Huhtinen K; Suvitie P; Perheentupa A
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):640-6. PubMed ID: 24734893
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?
Azzam AZ; Hashad DI; Kamel NA
Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457
[TBL] [Abstract][Full Text] [Related]
31. Utility Serum Marker HE4 for the Differential Diagnosis Between Endometriosis and Adnexal Malignancy.
Zapardiel I; Gorostidi M; Ravaggi A; Allende MT; Silveira M; Abehsera D; Macuks R
Int J Gynecol Cancer; 2016 Jan; 26(1):52-5. PubMed ID: 26512790
[TBL] [Abstract][Full Text] [Related]
32. Urinary levels of Bcl-2 are elevated in ovarian cancer patients.
Anderson NS; Bermudez Y; Badgwell D; Chen R; Nicosia SV; Bast RC; Kruk PA
Gynecol Oncol; 2009 Jan; 112(1):60-7. PubMed ID: 19007973
[TBL] [Abstract][Full Text] [Related]
33. Determination of sialic acid in saliva by means of surface-enhanced Raman spectroscopy as a marker in adnexal mass patients: ovarian cancer vs benign cases.
Zermeño-Nava JJ; Martínez-Martínez MU; Rámirez-de-Ávila AL; Hernández-Arteaga AC; García-Valdivieso MG; Hernández-Cedillo A; José-Yacamán M; Navarro-Contreras HR
J Ovarian Res; 2018 Jul; 11(1):61. PubMed ID: 30041680
[TBL] [Abstract][Full Text] [Related]
34. Correlation of serum, urinary and salivary CA 125 levels in patients with adnexal masses.
Tay SK; Chua EK
Ann Acad Med Singap; 1994 May; 23(3):311-4. PubMed ID: 7944239
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of urine HE4 in patients with ovarian cancer: a meta-analysis.
Jia MM; Deng J; Cheng XL; Yan Z; Li QC; Xing YY; Fan DM; Tian XY
Oncotarget; 2017 Feb; 8(6):9660-9671. PubMed ID: 28039447
[TBL] [Abstract][Full Text] [Related]
36. Effect of Serum Level of Human Epididymis Protein 4 and Interleukin-6 as Biomarkers in Patients with Adnexal Mass.
Hameed S; Abdulqader Jasim H; Sharief M
Arch Razi Inst; 2022 Oct; 77(5):1659-1671. PubMed ID: 37123162
[TBL] [Abstract][Full Text] [Related]
37. Serum human epididymis protein 4 can be a useful tumor marker in the differential diagnosis of adnexal masses during pregnancy: a pilot study.
Gucer F; Kiran G; Canaz E; Kilinc M; Ekerbicer HC; Avci F; Kiran H; Coskun A; Arikan DC
Eur J Gynaecol Oncol; 2015; 36(4):406-9. PubMed ID: 26390692
[TBL] [Abstract][Full Text] [Related]
38. HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review.
Karlsen NS; Karlsen MA; Høgdall CK; Høgdall EV
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2285-95. PubMed ID: 25169975
[TBL] [Abstract][Full Text] [Related]
39. The role of HE4 in ovarian cancer follow-up: a review.
Piovano E; Attamante L; Macchi C; Cavallero C; Romagnolo C; Maggino T; Landoni F; Gadducci A; Sartori E; Gion M; Zola P
Int J Gynecol Cancer; 2014 Oct; 24(8):1359-65. PubMed ID: 25054447
[TBL] [Abstract][Full Text] [Related]
40. [Ascites May Provide Useful Information for Diagnosis of Ovarian Cancer].
Stuchlíková E; Zahradníková M; Nenutil R; Valík D; Vojtěšek B; Novotný M; Hernychova L
Klin Onkol; 2017; 30(Supplementum1):187-190. PubMed ID: 28471203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
